These printable medical flash cards cover descriptions, risks, diagnoses and prevention of measles.
There are 11 flash cards in this set (2 pages to print.)
1. Print out the cards.
2. Cut along the dashed lines.
3. Fold along the solid lines.
Sample flash cards in this set:
|Description of Rubeola/ Measles/ First Disease||Acute, highly contagious viral disease with a characteristic rash. Associated with a significant degree of morbidity and mortality worldwide|
|Risk Factors for Rubeola||Lack of immunization (MMR given at 12 and 15 months) Waiting rooms with an infected pt (spread by microaerosolized resp droplets) Incubation period is 7-18 days, but usually 10 days Pts are contagious from 1-2 days prior to onset of symptoms until 4 days after appearance of the rash|
|Assessment Findings in Prodromal Stage (2-4 days) of Rubeola||Upper resp infxn symptoms Fever up to 104F The 3Cs: cough, coryza, and conjunctivitis Presence of Koplik's spots (white spots on buccal mucosa) is pathognomonic Malaise|
|Assessment Findings in Rash Phase of Rubeola||Emergence of maculopapular rash and elevation of temp up to 104.7F occur simultaneously Pharyngitis, cervical lymphadenopathy and splenomegaly often accompany rash Rash appears behind forehead and ears initially Over the first 24 hours, rash spreads to face, neck, and arms Next 24 hours, rash spreads to trunk and thighs Rarely rash can become hemorrhagic leading to fatality After 3-4 days, rash begins to clear and may leave a brownish discoloration and scaling|
|Diagnostic Studies for Rubeola||Measles specific IgM titers (must draw no sooner than 5 days after rash appears) Substantial rise in IgG titers between acute and convalescent phase Nasopharynx culture if done within 24 hours of onset of rash|
|Prevention of Rubeola||Routine vaccination at 12 and 15 months, that age 4-6 Resp isolation until 4 days after rash appears (Isolate immunocompromised pts for entire illness) Vaccination with live virus within 72 hours after exposure can provide protection Immunoglobulin if given within 6 days after exposure|
|Nonpharmacologic Management of Ruebola||Antipyretic measures Oral fluids Antitussives Room humidification|
|Pharmacologic Management of Rubeola||Water miscible vitamin A for children 6 months to 2 years in developing countries has been shown to decrease morbidity and mortality|
|Pregnancy Considerations in Rubeola||During pregnancy there is significant increase in fetal morbidity and mortality Immunoglobulin recommended for susceptible pregnant women who have been in contact with known rubeola pt|
|Consult/Referral for Rubeola||Report to local public health department Consider referral for all severe cases, prenant women, and immunocompromised pts|
|Expected Course for Rubeola||Mild to severe symptoms depending of age and immune status of pt|